Abstract:A common feature of many neurodegenerative diseases is the deposition of filamentous protein aggregates in the central nervous system (CNS), including neurofibrillary tangles (NFTs) composed of tau, and Lewy bodies (LBs) consisting of α-synuclein (α-syn), which are the hallmark lesions of Alzheimer's disease (AD) and Parkinson's disease (PD) respectively. What causes the conversion of normally soluble proteins into insoluble fibrils has always been enigmatic, and cell models that recapitulate the abnormal accumulation of tau into NFT-like aggregates were lacking due to high solubility of tau. Enlightened by in vitro studies showing nucleation-dependent fibrillization of tau, we tested the hypothesis that preformed tau fibrils (tau pffs) assembled from recombinant protein may act as seeds to nucleate the fibrillization of soluble tau in cultured cells. Indeed, we found that minute quantities of tau pffs internalized into cells over-expressing tau can rapidly recruit large amounts of endogenous tau into detergent-insoluble filamentous inclusions with properties very similar to NFTs. Moreover, the spontaneous uptake of tau pffs was shown to be mediated by endocytosis. Together with similar studies on tau and other disease-associated proteins, our study implicates cell-to-cell transmission of misfolded proteins through templated recruitment as a plausible mechanism for the onset and progression of CNS amyloidosis. Another mysterious phenomenon of neurodegenerative diseases is the frequent co-occurrence of different protein aggregates, such as NFTs and LBs. To test whether fibrillar α-syn can directly cross-seed tau into pathological aggregates, we utilized our recently developed synucleinopathy models in primary neurons and transgenic mice involving delivery of α-syn pffs. Intriguingly, we discovered two distinct strains of α-syn fibrils demonstrating striking difference in the efficiency of cross-seeding tau pathology both in neurons and transgenic mice. Biochemical analyses indicated conformational differences between the two strains, thereby revealing the ability of a single molecule to assemble into more than one misfolded conformers. We speculate that the existence of conformationally diverse strains may be another shared feature of amyloid aggregates, accounting for the tremendous heterogeneity of neurodegenerative diseases with differential extent of concomitant pathologies and highly variable but sometimes overlapping clinical symptoms.

Interactions of pathological proteins in neurodegenerative diseases

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception

Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases

Pathogenesis of Neurodegenerative Diseases Via Templated Recruitment

Multivalency drives interactions of alpha-synuclein fibrils with tau

The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease

Spreading of pathology in neurodegenerative diseases: a focus on human studies

A review of proposed mechanisms for neurodegenerative disease

Prion-Like Mechanisms in Parkinson’s Disease

Amyloid-beta, alpha-synuclein and tau aggregated co-pathologies enhance neuropathology and neuroinflammation

Interactions Between Α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders

Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

Synergy between amyloid-β and tau in Alzheimer’s disease

Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases

Amyloid-beta and tau protein beyond Alzheimer’s disease

Sequence of Molecular Events in the Development of Alzheimer's Disease: Cascade Interactions from Beta-Amyloid to Other Involved Proteins

α-synuclein in the pathophysiology of Alzheimer’s disease

Cell-to-cell Transmission of Pathogenic Proteins in Neurodegenerative Diseases